WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic cardiovascular disease involving thickening of the heart muscle and can potentially lead to debilitating symptoms and serious complications, including heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac death; and

WHEREAS, HCM is the most common inheritable heart disease and can affect anyone regardless of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general population; and

WHEREAS, An estimated 700,000 people in the United States have HCM, yet 85 percent of them may remain undiagnosed; and

WHEREAS, HCM shares symptoms with other common cardiovascular and pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to distinguish HCM from these other diseases; and

WHEREAS, All-cause mortality risk is three to four times higher in patients with HCM than that of the general population; and

WHEREAS, Knowing ones medical history and any signs and symptoms of HCM is an important first step in receiving an accurate diagnosis of HCM; and

WHEREAS, A health care provider must conduct a thorough screening with cardiac health questions to help identify a risk of cardiac disorders both genetic and congenital; and

WHEREAS, A health care provider may conduct several tests, including an echocardiogram, a cardiac MRI, or genetic testing to confirm a family history of HCM, and must examine the heart to diagnose HCM; and

WHEREAS, Following a diagnosis of HCM, it is important for patients to work with their health care provider to learn more about their disease and understand different management options, including prescription medicines and surgical treatment options that may help; and

WHEREAS, The fourth Wednesday in February is an appropriate day to observe Hypertrophic Cardiomyopathy Awareness Day; now, therefore, be it

Resolved by the Senate of the State of California, That the fourth Wednesday in February of each year is designated as Hypertrophic Cardiomyopathy Awareness Day in the State of California in order to raise public awareness about hypertrophic cardiomyopathy; and be it further

Resolved, That the Senate acknowledges the critical importance of hypertrophic cardiomyopathy awareness to improve cardiovascular health in the State of California; and be it further

Resolved, That the Senate supports raising awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy and the need to seek appropriate care for hypertrophic cardiomyopathy as a serious public health issue; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.

WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic cardiovascular disease involving thickening of the heart muscle and can potentially lead to debilitating symptoms and serious complications, including heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac death; and

WHEREAS, HCM is the most common inheritable heart disease and can affect anyone regardless of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general population; and

WHEREAS, An estimated 700,000 people in the United States have HCM, yet 85 percent of them may remain undiagnosed; and

WHEREAS, HCM shares symptoms with other common cardiovascular and pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to distinguish HCM from these other diseases; and

WHEREAS, All-cause mortality risk is three to four times higher in patients with HCM than that of the general population; and

WHEREAS, Knowing ones medical history and any signs and symptoms of HCM is an important first step in receiving an accurate diagnosis of HCM; and

WHEREAS, A health care provider must conduct a thorough screening with cardiac health questions to help identify a risk of cardiac disorders both genetic and congenital; and

WHEREAS, A health care provider may conduct several tests, including an echocardiogram, a cardiac MRI, or genetic testing to confirm a family history of HCM, and must examine the heart to diagnose HCM; and

WHEREAS, Following a diagnosis of HCM, it is important for patients to work with their health care provider to learn more about their disease and understand different management options, including prescription medicines and surgical treatment options that may help; and

WHEREAS, The fourth Wednesday in February is an appropriate day to observe Hypertrophic Cardiomyopathy Awareness Day; now, therefore, be it

Resolved by the Senate of the State of California, That the fourth Wednesday in February of each year is designated as Hypertrophic Cardiomyopathy Awareness Day in the State of California in order to raise public awareness about hypertrophic cardiomyopathy; and be it further

Resolved, That the Senate acknowledges the critical importance of hypertrophic cardiomyopathy awareness to improve cardiovascular health in the State of California; and be it further

Resolved, That the Senate supports raising awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy and the need to seek appropriate care for hypertrophic cardiomyopathy as a serious public health issue; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.

 THIRD READING 

Bill No: SR 14

Author: Becker (D)

Introduced: 2/7/23

Vote: Majority

SUBJECT: Hypertrophic Cardiomyopathy Awareness Day

SOURCE: Author

DIGEST:

This resolution designates the fourth Wednesday in February of each year is designated as “Hypertrophic Cardiomyopathy Awareness Day” in the State of California.

ANALYSIS: This resolution makes the following legislative findings:

1. Hypertrophic cardiomyopathy (“HCM”) is a chronic cardiovascular disease involving thickening of the heart muscle and can potentially lead to debilitating symptoms and serious complications, including heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac death.
2. HCM is the most common inheritable heart disease and can affect anyone regardless of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general population.
3. HCM shares symptoms with other common cardiovascular and pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to distinguish HCM from these other diseases.
4. Knowing one’s medical history and any signs and symptoms of HCM is an important first step in receiving an accurate diagnosis of HCM.
5. A health care provider must conduct a thorough screening with cardiac health questions to help identify a risk of cardiac disorders both genetic and congenital.
6. Following a diagnosis of HCM, it is important for patients to work with their health care provider to learn more about their disease and understand different management options, including prescription medicines and surgical treatment options that may help.

This resolution:

1. Designates the fourth Wednesday in February of each year as “Hypertrophic Cardiomyopathy Awareness Day” in the State of California in order to raise public awareness about hypertrophic cardiomyopathy.
2. Acknowledges the critical importance of hypertrophic cardiomyopathy awareness to improve cardiovascular health in the State of California.
3. Supports raising awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy and the need to seek appropriate care for hypertrophic cardiomyopathy as a serious public health issue.

FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No

SUPPORT: (Verified 2/15/23)

None received

OPPOSITION: (Verified 2/15/23)

None received

Prepared by: Karen Chow / SFA / (916) 651-1520

2/16/23 13:10:59

**** END ****